Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...

Cancerguard by Exact Sciences is the first of its kind early detection blood test for multiple kinds of cancer. Exact Sciences is a diagnostic company focusing on early cancer detection. Cancerguard ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Exact Sciences launched a blood test Wednesday that can detect many kinds of cancer, even before symptoms appear. It will become available from its website in October for $690. Best known for the ...

Diagnostics and imaging innovation is advancing rapidly, with new screening technologies expanding what's possible in early cancer detection. Providers need clear guidance on how to incorporate ...